KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $22.1 million.

  • Ginkgo Bioworks Holdings' Change in Accured Expenses rose 15270.36% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 18159.52%. This contributed to the annual value of -$40.4 million for FY2024, which is 33929.23% down from last year.
  • Ginkgo Bioworks Holdings' Change in Accured Expenses amounted to $22.1 million in Q3 2025, which was up 15270.36% from -$11.5 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Change in Accured Expenses high stood at $22.1 million for Q3 2025, and its period low was -$42.0 million during Q3 2024.
  • Moreover, its 5-year median value for Change in Accured Expenses was $2.3 million (2021), whereas its average is -$73210.5.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Change in Accured Expenses soared by 17816.96% in 2023, and later plummeted by 16481428.57% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Change in Accured Expenses (Quarter) stood at $15.2 million in 2021, then crashed by 282.85% to -$27.8 million in 2022, then surged by 178.17% to $21.7 million in 2023, then plummeted by 143.0% to -$9.3 million in 2024, then skyrocketed by 336.81% to $22.1 million in 2025.
  • Its Change in Accured Expenses was $22.1 million in Q3 2025, compared to -$11.5 million in Q2 2025 and $6.4 million in Q1 2025.